Term ends Mar 26, 2039 · High confidence
20-year base term ends Oct 23, 2038
Held by Crispr Therapeutics AG
Filed Oct 23, 2018 as application 16/168,823 · Granted Jan 26, 2021
Base term plus 154 days of patent term adjustment (USPTO delay)
Today
2018
2039
Clock starts
Oct 23, 2018
Oct 23, 2018
Term ends
Mar 26, 2039
Mar 26, 2039
Granted
Jan 26, 2021
Jan 26, 2021
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
154
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 154 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 23, 2018, when this application, 16/168,823, was filed | Oct 23, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +154 days, USPTO patent term adjustment record | Mar 26, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 26, 2039 | High confidence |
This family
| US 10,899,843 | this patent Mar 2039 | Mar 2039 |
| US 11,958,908 | In force no later than Mar 2039 | no later than Mar 2039 |
| Application 18/626,765 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 10, 2019 Reel 48852, frame 556 | Pearse, Bradley R.; Cooke, Michael; Boitano, Anthony; Palchaudhuri, Rahul; McDonough, Sean; Panwar, Rajiv | Magenta Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 29, 2019 Reel 50855, frame 905 | Distributed Bio, Inc. | Magenta Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 29, 2019 Reel 50871, frame 284 | Glanville, Jacob | Distributed Bio, Inc. | Assignment of Assignor's Interest |
| May 2, 2023 Reel 63517, frame 97 | Magenta Therapeutics, Inc. | Crispr Therapeutics AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Mar 2039
Term ends Mar 26, 2039. Maintenance fees still fall due before then
Note
The 154 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
7
later US patents cite this one
That is top 25% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.